Webinars » Webinar: mRNA & Protein Technologies in Diagnostics and Therapeutics | GenScript

Harnessing mRNA and Protein Technologies: New Frontiers in Diagnostics and Disease Management

The rapid advancements in mRNA and protein technologies are revolutionizing the way we approach diagnostics and disease management. From groundbreaking therapeutics to next-generation vaccines, these innovations are reshaping the biotech landscape.

Join us for an exclusive webinar where leading experts will explore groundbreaking research and real-world applications, offering valuable insights into the latest advancements in biologics and mRNA technologies.

Key Learning Objectives

Learn how to optimize the design-build-test cycle to accelerate biologic development and enhance therapeutic efficacy by leveraging advanced protein engineering strategies.

Gain a comprehensive understanding of bi-specific antibody development by exploring design technologies, production processes, and quality control measures through a real-world case study.

Discover how lipid nanoparticle (LNP) technology enhances mRNA-based drug delivery and enables the development of innovative therapeutics, including vaccines and beyond.

Understand the end-to-end process of mRNA synthesis with a one-stop solution that streamlines the workflow from gene design to the final mRNA product.

In this webinar, learn more on

Webinar Details

  • Dr. Alvin Chew, Senior Protein Scientist, GenScript Biotech Corporation
  • Dr. Alvin Chew earned a PhD in Structural Biology from NTU Singapore in 2022. He received the Dean’s Postdoctoral Fellowship at LKCMedicine, NTU, to develop nanobodies for detection and biotherapeutics. His expertise includes protein production, bioengineering, biophysical techniques, chromatography, mass spectrometry, and lab automation. His first-author publications provided key insights into flavivirus NS1 structures. He won 1st Prize (Post-Doctoral Category) at ICAR 2024 and contributed to CapQuant, a mass spectrometry-based RNA cap quantification technique published in Nature Protocols and Nucleic Acids Research. As president of LKCMedicine’s early researcher network, he was recognized for leadership, mentorship, and community service.
  • Dr. Yuxiao Liu, Senior mRNA Synthetic Scientist, GenScript Biotech Corporation
  • Dr. Yuxiao Liu earned her Ph.D. in Biomedical Engineering from Southeast University in 2021, focusing on capillary microfluidics and hydrogel microcarriers. She has published multiple SCI papers, including a review in Chemical Reviews. After her Ph.D., she advanced mRNA vaccine delivery at 1Globe Biomedical. Now a senior scientist at GenScript, she develops lipid nanoparticle (LNP) formulations for mRNA delivery, optimizing platforms for gene editing and targeted delivery. Combining academic research with industrial expertise, she drives innovation in mRNA technology and drug delivery.
  • Dr. Christian Nefzger, Group Leader, University of Queensland
  • After a Master's degree at the Technical University of Munich and training at Munich's Helmholtz Centre (Germany), Dr. Nefzger undertook doctoral studies at the Monash Institute for Pharmaceutical Sciences in Australia. Following postdoctoral work in Prof. Jose Polo's laboratory at the Australian Regenerative Medicine Institute (late 2011 onwards), he was appointed Group Leader of the Reprogramming and Ageing Laboratory at the Institute for Molecular Bioscience at UQ in 2019. He is an expert in reprogramming, epigenetics, and cellular ageing with >4500 citations and publications in renowned journals of Cell, Nature and Science families.
  • Associate Professor Jason Lee, Principal Research Fellow, University of Queensland
  • Associate Professor Jason Lee is a Group Leader of the Epigenetics and Precision Medicine Laboratory at Frazer Institute, The University of Queensland and holds Adjunct position at the Queensland University of Technology and Griffith University. He completed his doctorate degree at the University of Sydney on the study of growth factors in breast cancer. He then moved to Dana-Farber Cancer Institute, Harvard Medical School as a postdoctoral fellow for the study of nuclear receptors in breast cancer. Before joining UQ, Jason was a research fellow, then an Associate Professor at Seoul National University. He came back to Australia as a QIMR Berghofer International Research Fellow in 2013. He focuses on various research areas including molecular epigenetics, hypoxic signalling and cancer metastasis. A/Prof Lee has a commercialization program developing novel drugs for cancer therapy as well as biomarkers. He has undertaken a commercialization project at IP Group Australia to assess opportunities from across top research institutions and collaborate in creating and supporting a portfolio of spin-out companies.

Speaker-related Webinars

Latest Webinars

Find More Protein Categories »

Webinar: mRNA & Protein Technologies in Diagnostics and Therapeutics | GenScript

Webinar: mRNA & Protein Technologies in Diagnostics and Therapeutics | GenScript

AI-based Antibody Therapeutics Developability Assessment and Its Engineering

AI-based Antibody Therapeutics Developability Assessment and Its Engineering

Transforming Medicine: The Potential of Endothelial Cilia Proteins as Groundbreaking Biomarkers

Transforming Medicine: The Potential of Endothelial Cilia Proteins as Groundbreaking Biomarkers